Skillman, NJ, United States of America

James L Gaylor

This inventor holds 2 USPTO granted patents. Top assignee: E.i. Dupont De Nemours and Company. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James L Gaylor. Retrieved from https://idiyas.com/inventor/james-l-gaylor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of James L. Gaylor

Introduction

James L. Gaylor is a notable inventor based in Skillman, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid derivatives that serve as hypocholesterolemics. With a total of 2 patents to his name, Gaylor's work has had a meaningful impact on cholesterol management.

Latest Patents

Gaylor's latest patents focus on steroid derivatives that are effective in lowering cholesterol levels. These patents detail lanosterols substituted in the 14 and/or 15 positions, which are active in inhibiting lanosta-8,24-dien-3.beta.-ol 14.alpha.-methyl-demethylase activity. Additionally, they suppress 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity, thereby decreasing cholesterol synthesis and reducing serum cholesterol levels.

Career Highlights

James L. Gaylor is currently associated with E.I. du Pont de Nemours and Company, where he continues to innovate in the field of biochemistry. His work has been instrumental in advancing therapeutic options for individuals dealing with high cholesterol.

Collaborations

Gaylor has collaborated with several esteemed colleagues, including Paul R. Johnson and Soo Sung Ko. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

James L. Gaylor's contributions to the field of pharmaceuticals, particularly in cholesterol management, highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborations reflect a commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…